Indaptus Therapeutics Announces Private Placement Of 20,338,974 Shares For Gross Proceeds Of ~$24M
The Company currently intends to use the net proceeds from the Private Placement for working capital, research and development and other general corporate purposes, which may include early-stage research and preclinical
A small biotech company is selling new shares to raise about 24 million dollars for research and running the business. When a company sells many new shares, it can mean the stock gets spread thinner, so watch if the company makes real progress with its science.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.